Related Experiment Video

Updated: Feb 28, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K

Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients

Gunnar H Heine1, Kyrill S Rogacev2, Oliver Weingärtner3

  • 1Saarland University Medical Center, Homburg, Germany.

Seminars in Dialysis
|June 20, 2017
PubMed

Insights

Cardiovascular disease prevention in chronic kidney disease (CKD) differs from the general population. HDL-cholesterol is not a viable target, but LDL-cholesterol reduction shows promise, especially with combined statin/ezetimibe therapy for CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Lipid Metabolism

Background:

  • Cardiovascular disease (CVD) poses a significant burden for chronic kidney disease (CKD) patients.
  • Standard CVD prevention guidelines for individuals with normal kidney function are not directly applicable to CKD populations.
  • Lipid metabolism disorders are key drivers of atherosclerosis, necessitating tailored therapeutic strategies in CKD.

Discussion:

  • Unlike in the general population, high-density lipoprotein cholesterol (HDL-C) levels and cholesterol efflux capacity do not predict cardiovascular events in CKD patients.
  • Low-density lipoprotein cholesterol (LDL-C) reduction is beneficial for non-dialysis CKD patients, but its benefit in dialysis patients remains less clear.
  • CKD patients exhibit increased intestinal cholesterol absorption and decreased hepatic cholesterol synthesis, suggesting potential benefits from combination therapies.

Key Insights:

  • HDL-C should not be targeted for cardiovascular risk reduction in CKD patients.
  • Targeting LDL-C can reduce cardiovascular events in non-dialysis CKD patients.
  • Combined statin/ezetimibe therapy may offer particular advantages for CKD patients due to their distinct lipid metabolism.

Outlook:

  • Further research is needed to clarify the cardiovascular benefits of LDL-C targeting in dialysis CKD patients.
  • Investigating the efficacy of combined statin/ezetimibe therapy in specific CKD subgroups is warranted.
  • Personalized lipid management strategies are crucial for optimizing cardiovascular outcomes in the CKD population.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.2K
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

6.7K

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
529
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
863
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
485
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.7K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
801